Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Inge Johnsen

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Plos One|January 4, 2013
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastomaAgnes Rasmuson, Lova Segerström, Maria Nethander, et al.
Neuro-Oncology|August 22, 2008
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targetsNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
Neuro-Oncology|October 9, 2024
Development of an orthotopic medulloblastoma zebrafish model for rapid drug testingNiek van Bree, Ann-Sophie Oppelt, Susanne Lindström, et al.
Ebiomedicine|May 29, 2018
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor GrowthAnna Kock, Karin Larsson, Filip Bergqvist, et al.
Oncotarget|December 10, 2017
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability <i>in vitro</i> and impairs tumor growth <i>in vivo</i>Conny Tümmler, Igor Snapkov, Malin Wickström, et al.
Oncogene|December 14, 2018
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastomaØyvind H Hald, Lotte Olsen, Gabriel Gallo-Oller, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
British Journal of Cancer|September 22, 2022
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246Xiaolei Zhou, Gema Sanz Santos, Yue Zhan, et al.
Cancers|September 28, 2023
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal DevelopmentYe Yuan, Mohammad Alzrigat, Aida Rodriguez-Garcia, et al.
Cancers|December 10, 2021
<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural TumorsJelena Milosevic, Diana Treis, Susanne Fransson, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Plos One|January 4, 2013
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastomaAgnes Rasmuson, Lova Segerström, Maria Nethander, et al.
Neuro-Oncology|August 22, 2008
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targetsNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
Neuro-Oncology|October 9, 2024
Development of an orthotopic medulloblastoma zebrafish model for rapid drug testingNiek van Bree, Ann-Sophie Oppelt, Susanne Lindström, et al.
Ebiomedicine|May 29, 2018
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor GrowthAnna Kock, Karin Larsson, Filip Bergqvist, et al.
Oncotarget|December 10, 2017
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability <i>in vitro</i> and impairs tumor growth <i>in vivo</i>Conny Tümmler, Igor Snapkov, Malin Wickström, et al.
Oncogene|December 14, 2018
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastomaØyvind H Hald, Lotte Olsen, Gabriel Gallo-Oller, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
British Journal of Cancer|September 22, 2022
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246Xiaolei Zhou, Gema Sanz Santos, Yue Zhan, et al.
Cancers|September 28, 2023
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal DevelopmentYe Yuan, Mohammad Alzrigat, Aida Rodriguez-Garcia, et al.
Cancers|December 10, 2021
<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural TumorsJelena Milosevic, Diana Treis, Susanne Fransson, et al.
Pageof 9